RedC Biotech, founded by Dr. Ari Gargir, is developing a scalable platform to produce lab-grown, universal donor red blood cells from stem cells in large bioreactors. This innovation aims to alleviate chronic blood shortages globally, particularly in less developed regions where access and quality issues contribute to preventable deaths. The cultured cells could be produced in standardized facilities worldwide, ensuring reliable, safe, and on-demand transfusion products that bypass donor limitations and blood type matching complexities. RedC’s technology heralds a transformative approach to blood supply logistics, with potential to save millions of lives annually.